why choose us

First received: November 07, 2023

Clinical Trial: Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Polycystic Ovary Syndrome

Study Type: INTERVENTIONAL


Official Title: Comparing the Effects of Empagliflozin and Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

Brief Summary: this is open labelled randomize control trial among women with PCOS.PCOS, an endocrine condition, affects 5%-15% of premenopausal women.PCOS is characterized by atypical menstruation, ovulation difficulties, hyperandrogenemia, insulin resistance, and other metabolic abnormalities.Metformin is now an option for PCOS.The clinical reactions to metformin are limited and varied.Novel SGLT2 inhibitors treat type 2 diabetes with weight loss, insulin resistance reduction, and cardiovascular benefits.There is little…

Read more